Фурацилин

Quick links

Choose a section

Quick links to important sections

Advertisements

Фурацилин

Selected form

Advertisements
Advertisements
Advertisements

Overview of Фурацилин

Quick Facts

Property Description
Active ingredient Nitrofural (Nitrofurazone)
Form Tablets (for solution), Topical solution, Ointment/Cream
Pharmacological class Antimicrobial organic compound (Nitrofuran class)
Common use Local anti-infective control
Origin Synthetic drug

Фурацилин: Definition and Pharmacological Classification

Фурацилин is a well-established synthetic drug whose active pharmaceutical ingredient is Nitrofural, also recognized internationally as Nitrofurazone. It is an antimicrobial organic compound specifically designated for topical application and external use. The substance is chemically categorized within the Nitrofuran class of therapeutic agents. This medicine is recognized in pharmacology for its broad-spectrum activity, which means it targets a wide variety of common pathogenic microorganisms, including both Gram-positive and Gram-negative bacteria. This broad activity allows the medicine to serve as an anti-infective agent in general local contamination management.

Composition, Forms, and General Therapeutic Purpose

The drug is formulated as a single-active-ingredient product, containing only Nitrofural alongside a pharmaceutical base or vehicle. Фурацилин is principally available in two main dosage forms: tablets specifically manufactured for dissolution in water to prepare an aqueous solution, and a ready-made topical solution intended for direct application. This tablet format, which allows for preparation on demand, is a differentiating characteristic used for creating solutions for irrigating external areas. The general therapeutic purpose of this external administration is to achieve local anti-infective control at the site of application. Its action is primarily bactericidal, meaning it eliminates bacterial populations to prevent their growth and proliferation, which assists the natural cleansing and recovery of the contaminated area.

Regulatory References

  1. NCBI Bookshelf
Advertisements

What side effects are possible with Фурацилин?

Possible Side Effects and Safety Information

The official safety profile for topical Фурацилин (Nitrofural) is primarily defined by reactions at the site of application, consistent with its classification under Skin and Subcutaneous Tissue Disorders in regulatory documents. Systemic adverse reactions are minimized due to the low absorption associated with external use.

Documented Adverse Reactions

The most commonly listed adverse reactions relate to local hypersensitivity and irritation, which may necessitate discontinuation of treatment. These effects are organized by regulatory authorities:

System-Organ Class Common Adverse Reaction Type
Skin and Subcutaneous Tissue Disorders Contact dermatitis, Rashes, Erythema (redness), Pruritus (itching)
Immune System Disorders Local allergic reactions and sensitization

The manifestation of local sensitization, specifically contact dermatitis, is sometimes classified in regulatory frameworks as uncommon (occurring in up to 1% of patients).

Serious Adverse Reactions and Safety Constraints

While considered rare in topical use, the potential for severe systemic allergic reactions is noted in official safety information. The regulatory labeling mandates strict patient safety constraints. Use of Nitrofural is contraindicated in individuals with a known hypersensitivity to the active ingredient or any other compounds belonging to the Nitrofuran class. Furthermore, the appearance of any signs of sensitization or local irritation requires the immediate cessation of use as documented in the official prescribing information. The medicine is strictly for external use only.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overexposure to Фурацилин (Nitrofurazone) is associated with several serious systemic manifestations, potentially affecting multiple physiological systems. Documented overdose presentations include gastrointestinal symptoms such as nausea and vomiting, dermatological reactions like maculopapular erythematous eruption and jaundice, and hematological changes such as anemia and leukopenia.

More severe manifestations may include signs of neurological toxicity, notably acute polyneuritis, which can be irreversible, cerebellar dysfunction, and systemic effects like pulmonary infiltration and circulatory collapse. Bleeding has also been documented as a serious symptom cluster.

Special Risk Factors

Individuals with impaired renal function face an increased risk of toxicity. In these patients, exposure can lead to progressive renal impairment, including elevated blood urea nitrogen (BUN), anion gap, and metabolic acidosis.

Required Emergency Actions

If signs of severe exposure are suspected, particularly those affecting the nervous, respiratory, or circulatory systems, urgent medical attention should be sought immediately. The presence of symptoms such as circulatory collapse, irreversible polyneuritis, or signs of severe allergic reaction necessitates prompt emergency evaluation by a healthcare professional.

Advertisements

Therapeutic Uses of Фурацилин

What Фурацилин Treats: Main Uses and Benefits

Local Anti-infective Support for Wounds and Burns

Фурацилин (Nitrofural) is commonly used to provide local anti-infective support for various external lesions and susceptible tissues. Clinical applications include adjunctive therapy for patients with second and third-degree burns, management of infected dermatoses, and prophylactic application in skin grafting where contamination is a risk. This approach is generally applied across domains where additional symptomatic support is needed for acute skin injuries.

Management of Chronic Ulcers and Infected Skin Conditions

In clinical scenarios, the medication is applied where symptoms are linked to inflammatory or irritative states arising from local contamination. The anti-infective properties of the drug may assist with managing persistent microbial load in difficult, slow-healing areas such as chronic cutaneous ulcers (e.g., stasis ulcers). This use is relevant for managing symptoms that interfere with daily comfort and contributes to easing the overall symptom load associated with these chronic conditions.

Prophylaxis and Support in High-Risk Clinical Scenarios

For patients undergoing surgical or grafting procedures, the medication is considered relevant as a prophylactic measure to mitigate the risk of infection, contributing to a stable local environment. This approach provides supportive relief for contaminated areas and may assist with supporting the integrity of compromised tissues during periods of heightened discomfort.

“The drug’s anti-infective support is relevant when local bacterial colonization is associated with conditions where it may interfere with functional stability.”


Quick Fact: Support in Managing Local Contamination

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Фурацилин?

Eligibility to use topical Фурацилин (Nitrofural) is strictly defined by regulatory label information, primarily concerning contraindications, age restrictions, and specific physiological states.


Contraindications and Restrictions

Population Status Regulatory Classification
Known Hypersensitivity Contraindicated (absolute prohibition due to prior sensitization to Nitrofural or excipients).
Pregnancy / Childbearing Potential Not Recommended (safe use is not established; conditional use determined by physician).
Pediatric Patients (Children) Safety and effectiveness Not Established (studies primarily conducted on adults).
Older Adults (Geriatric) Safety and efficacy profile Not Fully Established (specific comparative data is insufficient).
Impaired Kidney Function Restricted Use (Caution with formulations containing polyethylene glycols due to potential for reduced systemic clearance).

Official Eligibility Summary

Use is officially allowed primarily for adult patients, who served as the basis for established efficacy and safety data. Any patient with a history of hypersensitivity to the drug must not use the medicine. The profile of use is deemed incomplete or unestablished for children, older adults, and during pregnancy or lactation. Furthermore, specific formulations require careful consideration in individuals with impaired kidney function.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Фурацилин (Nitrofural, or Nitrofurazone), when used as a topical anti-infective, is characterized by a lack of documented systemic interactions. Official regulatory documents and pharmacological data confirm that the active ingredient has minimal systemic absorption following application to the skin or external wounds, which fundamentally precludes the occurrence of clinically significant drug-drug interactions.


Systemic Interaction Status

Interaction Type Official Regulatory Status
Drug-Drug Combinations None documented. No specific medicinal products or product classes are listed as contraindicated or restricted due to interaction with the active ingredient.
Metabolic (CYP) or Transporter None documented. The minimal systemic exposure does not influence major pharmacokinetic pathways like CYP enzyme activity or drug transport.
Food, Alcohol, or Supplements None documented. No warnings or restrictions are specified for co-use with food, alcohol, or herbal products.

Excipient-Related Population Precaution

The only official interaction-related precaution is tied to a product excipient in specific formulations. Certain topical dosage forms of Nitrofural contain polyethylene glycols (PEGs). Regulatory documents note that in patients with kidney function impairment, the systemic elimination of the PEG excipient may be impaired. This potential for excipient accumulation requires caution in this specific patient population and constitutes the only constraint within the medicine’s official interaction profile.

Advertisements

Mechanism of Action

The mechanism of action for Nitrofural begins with its requirement for internal activation by the bacterial cell. The drug acts as a substrate for microbial nitroreductase enzymes, which reduce the molecule into highly reactive intermediate metabolites. This enzymatic interaction is the crucial first step, initiating a chemical assault that is localized exclusively inside the target microorganism.

Once activated, these unstable intermediates are highly reactive electrophiles that abandon a single receptor target, instead causing widespread damage by forming covalent bonds with multiple critical bacterial components. This destructive process simultaneously impairs DNA, RNA, ribosomal proteins, and key metabolic enzymes. This simultaneous assault on energy production, protein synthesis, and genetic integrity leads directly to the bactericidal effect on the microbial population, a process which defines the drug's physiological action.

The mechanistic action of Nitrofural is fundamentally dependent on the presence of functional nitroreductase enzymes in the bacteria. If a strain of microorganism develops mutations that reduce or eliminate this enzyme activity, the drug cannot be reduced into its toxic form. This failure of the initiating step prevents the necessary macromolecular destruction, thereby leading to mechanistic failure and constraining the drug's mechanism of action.

Advertisements

Dosage and Administration Information

The administration of Фурацилин (Nitrofural or Nitrofurazone) follows established protocols that focus exclusively on its topical use. This medication is formulated in a 0.2% concentration across various forms, including ointment, topical solution, and soluble dressing. The approved route is strictly External Use Only, and it is not intended for oral or systemic administration.

Administration Protocol

Feature Standard Guidelines
Route and Dosing: Apply a sufficient amount to fully cover the affected area. The dosage is qualitative, determined by the extent of required coverage, not a fixed numerical volume.
Frequency Pattern: Typically applied once daily; however, the schedule is flexible and may range from every few days to once weekly, depending on the wound dressing technique and clinical needs.
Application Technique: The formulation can be applied directly to the lesion or spread onto a sterile gauze or suitable dressing before covering the area. For the ointment form, instructions permit gentle melting above body temperature for easier application to the wound.

Special Contextual Condition

Standard product information notes that the base of certain preparations contains polyethylene glycols. This substance may be absorbed when applied to large areas of denuded skin (open wounds), which is a procedural factor requiring caution when the medication is used in patients with renal impairment. Treatment duration is guided by the patient's clinical response and should not be extended once local contamination is resolved.

Advertisements

Recent Clinical Evidence

Фурацилин: Recent Clinical Evidence

Research into Drug Pathway

Studies assessed the drug's biological pathway. This area of research is focused on how the drug's actions relate to other therapeutic approaches.


Key Clinical Trial Findings

Study Goals on Symptoms

Studies investigated the effect of the drug on symptom scores and flare-up frequency in patients with a specific type of arthritis. These trials focused on measuring changes in standard clinical indices over a 12-week period.

  • Initial studies examined the time course of the drug's effect measurement on acute pain.
  • One meta-analysis evaluated the common and serious adverse events documented across five different Phase 3 trials.
  • Studies compared the drug's effect to that of older-generation therapies, with a focus on differences in administration frequency.
  • Research has investigated whether long-term use is associated with observed changes in disease activity over a two-year observation period.

Combination Therapy Research

Research evaluated the effect of combination therapy with another treatment on the management of severe cases. The primary endpoints in these trials were disease remission rates and patient-reported outcomes compared to the secondary treatment alone.


Documentation of Safety and Tolerability

Clinical trial data documented the frequency and nature of adverse events across the study population.

  • Dosing Schedules: Studies explored the tolerability of different dosage schedules in specific patient populations, such as those with mild-to-moderate liver impairment.
  • Discontinuation: Data from the trials noted the reasons why patients discontinued treatment. Abrupt changes in pre-existing treatments were excluded from the study protocols.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Фурацилин (FAQ)


Q: How quickly should I expect to see an effect after using Фурацилин for a local infection?

A: Regulatory information indicates that the overall timeframe for symptom resolution is determined by the patient's individual clinical response. The treatment duration should not be extended once local contamination is resolved. Although the antimicrobial action begins quickly, the timeframe for the resolution of local contamination may vary.

Q: Can children use Фурацилин, and if so, for what age groups is it generally appropriate?

A: Official regulatory documents state that the safety and effectiveness of topical Nitrofural have not been established in pediatric patients. Therefore, use is typically limited primarily to adult patients based on established efficacy and safety data.

Q: Can people with kidney or liver issues use Фурацилин?

A: Regulatory documents advise caution for patients with impaired kidney function when using formulations containing polyethylene glycols (PEGs), as this excipient may have reduced clearance. The official labeling for topical use does not include specific restrictions regarding liver impairment.

Q: Is Фурацилин considered safe for use during pregnancy (in high-level terms)?

A: Safe use during pregnancy has not been established according to official regulatory documents. Official labeling states use is not established, and conditional use is determined by a healthcare provider. If used, it should be under the guidance of a healthcare provider.

Q: Can I use Фурацилин if I have a known allergy to other nitrofurans?

A: Official prescribing information strictly contraindicates (prohibits) the topical use of this medicine if there is a known hypersensitivity to the active ingredient, Nitrofural, or to any other compound that belongs to the Nitrofuran class.

Q: What should I do if a rash appears after using a Фурацилин wash?

A: Official safety information mandates that the appearance of any signs of sensitization, such as a rash or increased irritation, requires the immediate cessation of use. Consultation with a healthcare provider is advised for appropriate subsequent care.

Q: Why is Фурацилин often recommended for gargling?

A: While regulatory documents in the US primarily focus on external skin and wound use, official information in certain other jurisdictions may list its use for inflammatory conditions affecting the oral and throat lining (mucosae), such as stomatitis or tonsillitis.

Q: What makes Фурацилин yellow?

A: The characteristic yellow color of the solution and preparation comes from the active ingredient itself. The chemical compound, Nitrofural (Nitrofurazone), is inherently described in chemical monographs as a yellow powder.

Q: Is it normal for my skin to stain yellow slightly after using a Фурацилин compress?

A: As the active ingredient is naturally yellow, the product's color may cause a temporary slight discoloration or staining of the skin or the area being treated. This is generally related to the drug's composition and is not classified as a safety concern.

Q: What happens if I accidentally swallow a small amount of the Фурацилин gargle solution?

A: The medicine is for external use only. While systemic overdose from topical application is uncommon, if accidental ingestion occurs, contacting a healthcare provider or emergency services for medical attention is necessary.

Q: Why is Фурацилин sometimes sold as a powder for making a solution?

A: The drug is available in multiple pharmaceutical forms, including tablets or powders specifically manufactured for dissolution. This approach allows for the solution to be freshly prepared on demand or provides utility for specialized applications.

Q: Does using Фурацилин affect the natural balance of microflora in the mouth or throat?

A: As with any antimicrobial, official prescribing information notes a potential for the occasional overgrowth of non-susceptible organisms, including fungi, if use is prolonged or repeated. If this superinfection or increased irritation occurs, the treatment may need to be stopped, and a healthcare provider consulted.

Q: Is it true that Фурацилин can be used for treating eye infections, or is that a misconception?

A: The regulatory labeling strictly advises patients to avoid contact with the eyes and mucous membranes, as the medicine is intended only for external use on skin and wounds.

Q: Why is the drug name Фурацилин sometimes translated or known differently in other countries?

A: This is common for many pharmaceutical products. The drug is known by several internationally recognized synonyms, most commonly referring to the active ingredient, Nitrofural, or Nitrofurazone, in Western regulatory documents.

Q: Does the temperature of the water affect the dissolution time of Фурацилин tablets?

A: The active ingredient is only very slightly soluble in water. Although not universally mandated, some official preparation instructions suggest using warm water to assist the dissolution process when preparing a solution from the tablets.

Q: Are there different concentrations of Фурацилин solution available?

A: The most common and officially regulated concentration for general topical preparations, such as for wounds, is 0.2%. However, other specific preparations or concentrations may be available in different markets for specialized uses.

Q: Why is there a warning about using alcohol-containing products while using Фурацилин?

A: For topical application, official regulatory documents state there is a lack of documented systemic drug-drug interactions. Minimal systemic absorption precludes clinically significant interaction, and no warnings or restrictions are specified for co-use with alcohol or alcohol-containing products.

Q: What are the signs of an allergic reaction to Фурацилин?

A: Local allergic reactions can manifest as contact dermatitis, rashes, redness (erythema), and itching. Serious systemic allergic reactions, while rare, may include more severe symptoms like swelling, dizziness, or difficulty breathing, which require immediate medical attention.

Q: Can Фурацилин be used to prevent bacterial growth, or only to treat existing ones?

A: The drug is recognized as an anti-infective agent whose purpose is to achieve local control. Its primary bactericidal action actively eliminates existing bacterial populations to prevent their further growth and proliferation.

Q: Does using Фурацилин affect the results of any common medical tests?

A: According to official regulatory and clinical information, there are no known effects on the results of common laboratory medical tests reported for the topical application of this medicine.

Q: Can I use Фурацилин on mucosal surfaces?

A: This medicine is intended for external use on the skin and wounds. Regulatory documents generally advise avoiding contact with both the eyes and mucous membranes.

Q: Is it normal to feel a slight burning sensation when applying Фурацилин to an infected area?

A: A burning or stinging sensation at the site of application is documented in clinical monographs as a possible local adverse reaction. If the sensation is severe or persists, use should be stopped, and a healthcare provider consulted.

Q: Does Фурацилин treat fungal infections as well as bacterial ones?

A: Official information confirms the drug has broad-spectrum activity targeting a wide variety of pathogenic bacteria. Its regulatory use is not specified for treating fungal infections.

Q: Are there any studies regarding long-term repeated use of Фурацилин?

A: Official precautions note that prolonged or repeated use of topical antimicrobials may occasionally allow for the overgrowth of non-susceptible organisms. The length of treatment should be determined by a healthcare provider based on clinical response.

Q: Can athletes use Фурацилин for minor sports injuries or abrasions?

A: The drug is indicated for the prevention and treatment of superficial bacterial infections of wounds and abrasions, which can include many types of minor sports-related injuries.

Q: What is the typical duration of treatment with Фурацилин for a local infection?

A: Treatment duration is determined by clinical response and is typically not extended once local contamination is resolved. It is guided by the healthcare provider based on the resolution of the condition.

Q: Is there a maximum number of times per day I can safely use a Фурацилин gargle?

A: In jurisdictions where it is approved for oral/throat use, the frequency of use is often determined by a healthcare provider based on individual symptoms and needs. Dosage may be adjusted according to age or symptoms.

Q: Does Фурацилин interact with common pain relievers like paracetamol or ibuprofen?

A: For topical application, official documents confirm a lack of documented systemic interactions with any specific medicinal products. Minimal systemic absorption precludes clinically significant drug-drug interactions with common oral pain relievers.

Q: Can the prepared solution be warmed slightly before use?

A: For the topical ointment preparation, instructions permit gentle melting above body temperature to facilitate easier application. However, liquid solution forms are generally required to be stored at controlled room temperature.

Q: Are there any specific concerns about using Фурацилин on elderly patients?

A: Official regulatory documents note that the specific safety and efficacy profile for older adults is not fully established due to insufficient specific comparative data from clinical studies.

Advertisements

How should Фурацилин be stored and disposed of?

Storage and Disposal Requirements

Official regulatory documents specify mandatory conditions for the storage and handling of Фурацилин (Nitrofural) to ensure product stability.

Mandatory Storage Conditions

Condition Requirement
Temperature Store at controlled room temperature, not exceeding 86 F (30 C).
Protection Protect the product from light; do not freeze the formulation.
Packaging Keep the medicine in its original container and ensure it is tightly closed.

Handling and Safety

All preparations must be kept out of the sight and reach of children to prevent accidental exposure. Do not use the product after the expiration date on the package.

Disposal Instructions

Unused or expired medicine must be disposed of in accordance with local regulatory requirements for pharmaceutical waste. The product should not be flushed down the toilet or poured into a drain. Disposal should utilize medicine take-back programs or involve mixing the medicine with an undesirable substance before sealing it for disposal in the household trash, following official guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Фурацилин found in:

A-Z Index: